The global spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has called for an urgent need for the identification of compounds...
A team of researchers from Sorrento Therapeutics, Inc. has isolated a new antibody that completely inhibits the SARS-CoV-2 coronavirus virus in cell culture.
Colorized...
SARS-CoV-2, a novel coronavirus that causes the COVID-19 disease, uses a receptor called angiotensin-converting enzyme 2 (ACE2) to gain entry into human...
SARS-CoV-2, a novel coronavirus that causes the COVID-19 disease, can infect enterocytes in the intestine and multiply there, according to a study by researchers...
A new study published in the journal Cell pinpoints the likely cell types SARS-CoV-2, a new coronavirus behind the COVID-19 disease, infects; it also shows...
According to a new study published in the European Respiratory Journal, smokers and individuals with chronic obstructive pulmonary disease (COPD) have...
A trial drug called APN01 or human recombinant soluble ACE2 (hrsACE2) can significantly block early stages of SARS-CoV-2 infections, according to a paper...
Two new papers published in the journal Antimicrobial Agents and Chemotherapy provide a summary of therapeutic compounds that showed potential in fighting...
Chemists at the Massachusetts Institute of Technology (MIT) have chemically synthesized a new peptide (a short protein fragment) that can bind to part...
Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) may increase the risk of severe COVID-19 cases, according to...
There’s been some confusion recently on whether we should or shouldn’t take ibuprofen to treat symptoms of COVID-19, especially after the World Health...
In a new study, a team of researchers from the University of Minnesota and the University of North Carolina has analyzed the potential receptor usage by...
